Internal Medicine, Gastroenterology · Kalamazoo, MI
NPI
1194787861
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
1535 Gull Rd, Suite 105
Kalamazoo, MI, 49048
Phone (269) 385-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,021 services
Medicare patients, 2024
452
Average age 73
Drug cost, 2024
$949K
2,277 prescriptions
Company payments, 2025
$318
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brij M Dewan was code 45380 (lower gi endoscopy - other), 124 times for 123 patients. In total Brij M Dewan billed 1,021 services in 47 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Facility | 124 | 123 | $99.95 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 120 | 55 | $59.70 | $7,164 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 100 | 99 | $3.91 | $391 |
| 99214 Office E&M - Established | Facility | 98 | 84 | $66.81 | $6,548 |
| 99214 Office E&M - Established | Office | 95 | 79 | $77.39 | $7,352 |
| 43239 Upper GI Endoscopy | Facility | 86 | 83 | $70.77 | $6,086 |
| 45385 Colonoscopy - Lesion Removal | Facility | 65 | 63 | $181.77 | $12K |
| 99222 Hospital E&M - Initial | Facility | 55 | 54 | $92.69 | $5,098 |
| 45378 Lower GI Endoscopy - Other | Facility | 31 | 31 | $104.33 | $3,234 |
| 43249 Upper GI Endoscopy | Facility | 26 | 25 | $102.09 | $2,654 |
| 99204 Office E&M - New | Office | 19 | 19 | $105.90 | $2,012 |
| 99204 Office E&M - New | Facility | 19 | 19 | $95.48 | $1,814 |
| 99213 Office E&M - Established | Office | 18 | 18 | $44.64 | $803 |
| 43235 Upper GI Endoscopy | Facility | 15 | 14 | $68.48 | $1,027 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 13 | 13 | $175.66 | $2,284 |
By year: 2022 $133K for 4,651 services; 2023 $102K for 1,162 services; 2024 $86K for 1,021 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brij M Dewan prescribed most often to Medicare patients was Omeprazole, with 498 prescriptions and refills. In total Brij M Dewan wrote 2,277 Medicare prescriptions that cost $949K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 498 | 894 | 145 | $8,908 |
| Pantoprazole Sodium Generic | 492 | 895 | 158 | $11K |
| Dicyclomine Hcl Generic | 150 | 224 | 50 | $2,347 |
| Colestipol Hcl Generic | 149 | 246 | 53 | $21K |
| Linzess Linaclotide | 100 | 112 | 34 | $59K |
| Famotidine Generic | 98 | 178 | 34 | $1,188 |
| Rabeprazole Sodium Generic | 79 | 96 | 23 | $3,058 |
| Mesalamine Generic | 73 | 117 | 23 | $32K |
| Budesonide Dr Budesonide | 48 | 75 | 16 | $5,266 |
| Esomeprazole Magnesium Generic | 41 | 59 | Under 11 | $1,291 |
| Sulfasalazine Dr Sulfasalazine | 39 | 51 | Under 11 | $1,360 |
| Metoclopramide Hcl Generic | 38 | 41 | 19 | $271 |
| Mesalamine Er Mesalamine | 32 | 48 | Under 11 | $5,121 |
| Lansoprazole Generic | 27 | 65 | Under 11 | $766 |
| Creon Lipase/Protease/Amylase | 26 | 34 | Under 11 | $59K |
Brand drugs: 340 claims; generic drugs: 1,937 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brij M Dewan $318 ($318 in general payments such as food, travel and fees) from 3 companies. The largest payer was Ardelyx, Inc. with $112.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.